Published • loading... • Updated
The US Government Didn’t Legalize Marijuana: 4 Cannabis Misconceptions Explained
The move lets state-licensed businesses deduct expenses and could lead to retroactive refunds, while researchers face fewer federal barriers.
- On April 23, The Justice Department reclassified state-licensed or FDA-approved medical marijuana products as Schedule III drugs, enabling businesses to receive standard tax deductions under federal law.
- Previously classified as a Schedule I drug alongside LSD, marijuana now joins substances like Tylenol with codeine in Schedule III, though the federal government maintains this does not federally legalize recreational use.
- University of Mississippi public health professor Andrew Yockey said, "In reality, research shows it has a mixed risk profile," warning that many incorrectly assume marijuana is completely safe.
- Reducing administrative burdens for scientists, the reclassification aligns with a 2022 law; Beau Kilmer, co-director of RAND's Drug Policy Research Center, noted that researchers may now feel more comfortable studying cannabis products.
- According to the National Survey on Drug Use and Health, substance use disorder rates involving marijuana were 3.7 times higher in 2024 than in 2015, remaining the second most prevalent disorder for people 12 and older.
Insights by Ground AI
26 Articles
26 Articles
Coverage Details
Total News Sources26
Leaning Left1Leaning Right0Center25Last UpdatedBias Distribution96% Center
Bias Distribution
- 96% of the sources are Center
96% Center
C 96%
Factuality
To view factuality data please Upgrade to Premium
